A Kennedy no le gusta Ozempic, esto es lo que podría hacer al respectonews2024-11-26T08:00:57+00:00November 26th, 2024|The New York Times|
Dr Martin Makary Chosen to Head the FDAnews2024-11-23T02:15:50+00:00November 23rd, 2024|The New York Times|
Can RFK Jr. Limit Ozempic Access as HHS Chief? Here’s What to Knownews2024-11-22T21:06:45+00:00November 22nd, 2024|The New York Times|
F.D.A.: Some Clonazepam Recalled Over Incorrect Doses on Labelsnews2024-11-22T17:26:32+00:00November 22nd, 2024|The New York Times|
Kennedy’s Views Mix Mistrust of Business With Unfounded Health Claimsnews2024-11-16T03:21:15+00:00November 16th, 2024|The New York Times|
Richard Pazdur, FDA Cancer Chief, Discusses 25 Years of Innovationnews2024-11-09T01:04:06+00:00November 9th, 2024|The New York Times|
F.D.A. Wants to Pull Ineffective Decongestant From Storesnews2024-11-07T20:31:25+00:00November 7th, 2024|The New York Times|
From AI to Musk’s Brain Chip, the F.D.A.’s Device Unit Faces Rapid Changenews2024-11-01T23:57:56+00:00November 1st, 2024|The New York Times|
How a Second Trump Term Could Recast Public Healthnews2024-11-01T01:21:05+00:00November 1st, 2024|The New York Times|
R.F.K. Jr. Said Trump Promised Him Control of Public Health Agencies. The Campaign Called That Premature.news2024-10-30T18:32:40+00:00October 30th, 2024|The New York Times|
